Index of reports
> Serious Reactions (197)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 197 Next >>
Possible Omniscan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Omniscan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: male
Reactions: Abasia, Pain, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Limb Discomfort, Grip Strength Decreased, Mobility Decreased, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2006-11-13
Gadolinium IN Unspecified Drug
Indication: Renal Transplant
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin
Possible Omniscan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: male
Reactions: Pain, Abasia, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Grip Strength Decreased, Skin Fibrosis, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-11-13
Gadolinium IN Unspecified Drug
Indication: Renal Transplant
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin
Possible Omniscan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Hyperkeratosis, Pain in Extremity, Bone Pain, Pain, Musculoskeletal Pain, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Hypoaesthesia, DRY Skin, Arthralgia, Oedema, Skin Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-06-06
End date: 2005-06-06
Gadolinium IN Unspecified Drug
Indication: Pancreatic Mass
Magnevist
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-05-07
End date: 2003-05-07
Omniscan
Dosage: 20 ml (daily dose), once, intravenous
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-08-12
End date: 2002-08-12
Other drugs received by patient: Norvasc; Labetalol HCL; Accupril; Nifedipine; Sensipar; Lisinopril; Dicyclomine; Nitroprusside Sodium; Epoetin NOS; Carvedilol; Hyoscyamine Sulfate; Epogen; Phenytoin; Minoxidil; Sucralfate; Losartan Potassium; Clonidine; Lopressor; Phoslo; Procardia XL; Valtrex; Hydralazine HCL; Coumadin; Renagel; Divalproex Sodium; Nifedipine
Possible Omniscan side effects in 49 year old male
Reported by a lawyer from United States on 2012-08-02
Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Start date: 2004-05-19
End date: 2004-05-19
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-19
End date: 2006-05-19
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-13
End date: 2006-10-13
Magnevist
Dosage: 20 ml, unk
Start date: 2006-10-17
End date: 2006-10-17
Multihance
Indication: Product Used FOR Unknown Indication
Omniscan
Omniscan
Dosage: 50 ml omniscan+co2
Indication: Fistulogram
Start date: 2006-08-04
End date: 2006-08-04
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-05
End date: 2006-08-05
Optimark
Indication: Product Used FOR Unknown Indication
Prohance
Indication: Computerised Tomogram Head
Start date: 2004-05-19
End date: 2004-05-19
Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine
Possible Omniscan side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Possible Omniscan side effects in male
Reported by a lawyer from United States on 2012-08-01
Patient: male
Reactions: Quality of Life Decreased, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Deformity, Anxiety, Emotional Distress, Fibrosis, Injury, Scar, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Start date: 2004-11-23
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2003-05-10
Omniscan
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-06-25
Omniscan
Dosage: unk
Start date: 2004-10-15
Omniscan
Dosage: unk
Start date: 2004-10-04
Omniscan
Dosage: unk
Start date: 2005-03-18
Possible Omniscan side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-27
Patient: female
Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Possible Omniscan side effects in 53 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 53 year old female
Reactions: Arthralgia, Induration, Musculoskeletal Stiffness, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Tightness
Drug(s) suspected as cause:
Omniscan
Indication: Diagnostic Procedure
Omniscan
Indication: Product Used FOR Unknown Indication
Possible Omniscan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Hyperkeratosis, Pain in Extremity, Pain, Musculoskeletal Pain, Bone Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, DRY Skin, Arthralgia, Oedema, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-05-07
End date: 2003-05-07
Omniscan
Dosage: 20 ml (daily dose), once, intravenous
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-08-12
End date: 2002-08-12
Other drugs received by patient: Divalproex Sodium; Coumadin; Sensipar; Lisinopril; Nitroprusside Sodium; Nifedipine; Carvedilol; Sucralfate; Valtrex; Clonidine; Nifedipine; Accupril; Phenytoin; Phoslo; Hyoscyamine Sulfate; Norvasc; Procardia XL; Lopressor; Labetalol HCL; Hydralazine HCL; Epoetin NOS; Dicyclomine; Minoxidil
Possible Omniscan side effects in 79 year old female
Reported by a physician from United States on 2012-07-20
Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Gadolinium Zeolite
Start date: 2005-08-16
End date: 2005-08-16
Gadolinium Zeolite
Start date: 2001-05-03
End date: 2001-05-03
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2001-03-05
End date: 2001-03-05
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Magnevist
Indication: Angiogram
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: dose reported as eight 20ml vials (160ml)
Start date: 2005-09-20
End date: 2005-09-20
Omniscan
Dosage: route reported as ^first via distal port and then via the proximal port^
Indication: Angiogram
Start date: 2003-12-04
End date: 2003-12-04
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-05-23
End date: 2003-05-23
Omniscan
Dosage: dose reported as ^11^ 20ml vials
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Optimark
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-08-16
End date: 2005-08-16
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar
Possible Omniscan side effects in 49 year old female
Reported by a consumer/non-health professional from United States on 2012-07-18
Patient: 49 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Skin Wrinkling, Joint Stiffness, Oedema Peripheral, Melanocytic Naevus, Fibrosis, Arthrofibrosis, General Physical Health Deterioration, Hypoaesthesia, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Paraesthesia, Skin Tightness, Scar, Abasia, Pain, Joint Contracture, Skin Hyperpigmentation, Muscle Tightness, Tendon Pain, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Injury, Joint Ankylosis, Extremity Contracture, Myocardial Fibrosis, Dyspnoea, Rash Papular, Musculoskeletal Pain, Skin Disorder, Muscular Weakness, Rash Macular, Pulmonary Fibrosis, Arthralgia, Gait Disturbance, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Start date: 2004-05-20
End date: 2004-05-20
Magnevist
Start date: 1999-11-09
End date: 1999-11-09
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 1997-04-30
End date: 1997-04-30
Magnevist
Start date: 1998-12-31
End date: 1998-12-31
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1996-10-30
End date: 1996-10-30
Magnevist
Start date: 2002-01-30
End date: 2002-01-30
Magnevist
Start date: 2005-01-30
End date: 2005-01-30
Magnevist
Start date: 1997-11-17
End date: 1997-11-17
Magnevist
Dosage: 9.7 ml, once
Start date: 2003-03-20
End date: 2003-03-20
Magnevist
Start date: 2000-11-08
End date: 2000-11-08
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-01-30
End date: 2005-01-30
Omniscan
Start date: 2005-03-20
End date: 2005-03-20
Omniscan
Dosage: unk
Other drugs received by patient: Thyroid Therapy; Ferrous Sulfate TAB; Miacalcin; Cytoxan; Oxandrin; Folic Acid; Procardia; Synthroid; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Advair Diskus 100 / 50; Zemplar; Aranesp; Aleve; Prograf; Epogen; Exforge; Activase; Celebrex; Zestril; Renagel; Metoprolol Succinate; Amigen; Prempro; Rocaltrol; Spironolactone; Demadex; Sensipar; Myfortic; Prednisone; Clonidine; Amlodipine Besylate
Possible Omniscan side effects in 44 year old female
Reported by a physician from United States on 2012-07-18
Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)
Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-02-06
Optimark
Dosage: unk
Indication: Angiogram
Start date: 2005-05-31
Optimark
Dosage: unk
Start date: 2005-08-31
Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc
Possible Omniscan side effects in 54 year old male
Reported by a lawyer from United States on 2012-07-17
Patient: 54 year old male
Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Muscle Rigidity, Neuropathic Ulcer, Erythema, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Arthralgia, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-11-29
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-12-12
End date: 2000-12-12
Omniscan
Indication: Arthralgia
Omniscan
Indication: Sepsis
Other drugs received by patient: Lansoprazole; Atacand HCT; Vitamin E; Verapamil HCL; Minoxidil; Misoprostol; Lorazepam; Amiodarone HCL; Humulin R; Phoslo; Vitamin D; Epoetin Alfa; Cytotec; Calcium Acetate; Cefazolin Sodium
Possible Omniscan side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf
Possible Omniscan side effects in 51 year old female
Reported by a lawyer from United States on 2012-07-09
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis Device Insertion
Multihance
Indication: Fistulogram
Multihance
Indication: Venogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Fistulogram
Omniscan
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Venogram
Optimark
Indication: Fistulogram
Prohance
Indication: Venogram
Prohance
Indication: Fistulogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl
Possible Omniscan side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female
Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Magnevist
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Possible Omniscan side effects in female
Reported by a physician from Germany on 2012-07-03
Patient: female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Omniscan
Possible Omniscan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 54 year old male
Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-11-29
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec
Possible Omniscan side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-28
Patient: male, weighing 83.0 kg (182.6 pounds)
Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Magnevist
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-05-18
End date: 1998-05-18
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor
Possible Omniscan side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin
Possible Omniscan side effects in 58 year old female
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, unk
Indication: Imaging Procedure
Start date: 2003-12-20
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-05-26
End date: 2005-05-26
Magnevist
Dosage: 15 ml, unk
Indication: Angiogram
Start date: 2006-05-30
Multihance
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps
Possible Omniscan side effects in 52 year old female
Reported by a physician from Japan on 2012-06-21
Patient: 52 year old female, weighing 35.0 kg (77.0 pounds)
Reactions: Pneumonia, Nephrogenic Systemic Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Start date: 2004-07-07
End date: 2004-07-07
Magnevist
Dosage: 7 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-05-14
End date: 2003-05-14
Magnevist
Indication: Aortic Stenosis
Start date: 2004-03-17
End date: 2004-03-17
Magnevist
Dosage: 15 ml, once
Start date: 2005-08-30
End date: 2005-08-30
Magnevist
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 15 ml, once
Start date: 2005-05-25
End date: 2005-05-25
Magnevist
Dosage: 15 ml, once
Start date: 2004-12-29
End date: 2004-12-29
Magnevist
Indication: Angiogram
Start date: 2003-07-08
End date: 2003-07-08
Omniscan
Start date: 2005-09-09
End date: 2005-09-09
Omniscan
Start date: 2005-12-21
End date: 2005-12-21
Omniscan
Dosage: 7 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-24
End date: 2003-09-24
Omniscan
Start date: 2005-08-03
End date: 2005-08-03
Omniscan
Start date: 2003-11-26
End date: 2003-11-26
Omniscan
Start date: 2005-03-16
End date: 2005-03-16
Other drugs received by patient: Lidocaine; Levothyroxine Sodium; Pursennide; Prednisolone; Losartan Potassium; Diastase; Heparin Calcium; Lansoprazole; Pursennide; Levothyroxine Sodium; Renagel
Possible Omniscan side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Post Thrombotic Syndrome, Skin Discolouration, Induration, Oedema Peripheral, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Verapamil; Lasix; Coumadin; Clonidine; Epogen; Minoxidil; Albuterol; Calcitriol; Lanoxin; Renagel; Sensipar; Glyburide; Flovent; Insulin; Iron Sulfatethiamin Compound TAB
Possible Omniscan side effects in male
Reported by a lawyer from United States on 2012-06-20
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Hyperkeratosis, Pain in Extremity, Pain, Musculoskeletal Pain, Bone Pain, DRY Skin, Hypoaesthesia, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Arthralgia, Oedema, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-05-07
End date: 2003-05-07
Omniscan
Dosage: 20 ml (daily dose), once, intravenous
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-08-12
End date: 2002-08-12
Other drugs received by patient: Labetalol HCL; Procardia XL; Sucralfate; Accupril; Divalproex Sodium; Carvedilol; Norvasc; Phenytoin; Dicyclomine; Nitroprusside Sodium; Phoslo; Lisinopril; Clonidine; Nifedipine; Coumadin; Sensipar; Hyoscyamine Sulfate; Nifedipine; Hydralazine Hydrochloride; Epoetin NOS; Minoxidil
Possible Omniscan side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Post Thrombotic Syndrome, Oedema Peripheral, Induration, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Albuterol; Minoxidil; Renagel; Insulin; Calcitriol; Lanoxin; Verapamil; Lasix; Epogen; Sensipar; Flovent; Coumadin; Glyburide; Clonidine; Iron Sulfatethiamin Compound TAB
Possible Omniscan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 54 year old male
Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Possible Omniscan side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 59 year old male
Reactions: Coronary Artery Disease, Atrial Fibrillation, Muscular Weakness, Venous Insufficiency, Nephrogenic Systemic Fibrosis, Hemiparesis, Cardiomyopathy, Cardiogenic Shock, Cerebrovascular Accident, Post Thrombotic Syndrome, Skin Discolouration, Induration, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Verapamil; Minoxidil; Insulin; Sensipar; Albuterol; Calcitriol; Epogen; Lanoxin; Renagel; Coumadin; Iron Sulfatethiamin Compound TAB; Glyburide; Clonidine; Flovent; Lasix
Possible Omniscan side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-11
Patient: 71 year old male, weighing 58.8 kg (129.4 pounds)
Reactions: Musculoskeletal Stiffness, Skin Disorder, Nephrogenic Systemic Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2003-02-25
End date: 2003-02-25
Omniscan
Start date: 2001-12-18
End date: 2001-12-18
Omniscan
Start date: 2003-04-30
End date: 2003-04-30
Omniscan
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2001-12-11
End date: 2001-12-11
Other drugs received by patient: Ceftazidime Sodium; Digoxin; Cefotiam Hydrochloride; Allopurinol; Aspirin; Unasyn; Alosenn; Cefazolin; Cefdinir; Cefazolin; Famotidine; Loxonin; Cefazolin; Wasser V V; Calcium Carbonate; Neuer; Pursennid
Possible Omniscan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Contrast Media
Indication: Decubitus Ulcer
Start date: 2005-04-14
End date: 2005-04-14
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Magnevist
Multihance
Indication: Diagnostic Procedure
Omniscan
Indication: Liver Disorder
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Neck Pain
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Osteomyelitis
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Optimark
Prohance
Indication: Renal Mass
Start date: 2003-07-03
End date: 2003-07-03
Prohance
Indication: Renal Scan
Start date: 2003-07-03
End date: 2003-07-03
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx
Page 1 Next >>
|